Drug Trial Radar · NCT07420816
Efficacy and Safety of APSTZD in the Treatment of Insomnia Disorder
Last checked: Nov 20, 2026Latest source record: Aug 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
222
Planned (sponsor's estimate)
Start
Aug 5, 2026
Primary completion
Dec 2027
Study completion Dec 2027
Sponsor
- Lead sponsor
- Apsen Farmaceutica S.A.Industry
- Sponsor type
- Industry
- First posted
- Feb 19, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy of APSTZD compared to one active drug and placebo in insomnia treatment.
Conditions
- Insomnia
- Insomnia Chronic
Interventions
APSTZD 1Drug
APSTZD + placebo test 2 + placebo test 3 + placebo test 4 + comparator placebo 1
APSTZD 2Drug
APSTZD + placebo test 1 + placebo test 3 + placebo test 4 + comparator placebo 1
APSTZD 3Drug
APSTZD + placebo test 1 + placebo test 2 + placebo test 4 + comparator placebo 1
APSTZD 4Drug
APSTZD + placebo test 1 + placebo test 2 + placebo test 3 + comparator placebo 1
Stilnox CR®Drug
Stilnox CR® + placebo test 1 + placebo test 2 + placebo test 3 + placebo test 4
PlaceboDrug
placebo test 1 + placebo test 2 + placebo test 3 + placebo test 4 + comparator 1
Primary outcomes
What the sponsor says the trial is designed to measure.
- Reduction in WASO 6h (Wake After Sleep Onset) assessed by polysomnographyTime frame: Change from baseline after 2 weeks of treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
UNIFAG - Casa Nossa Senhora da PAZ -ASF
Bragança Paulista, São Paulo, Brazil · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.